Lebrikizumab Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH5058
Add to Compare
$306.00

Lebrikizumab Biosimilar - Research Grade

Product Information:

ichorbio’s Tralokinumab Biosimilar is for Research Use Only (RUO)

Target:

IL-13

Size:

ichorbio’s biosimilars are available in the following sizes: 1mg, 5mg, 10mg, 20mg, 50mg, 100mg

Isotype:

Human IgG4P-Kappa

Host:

CHO Cells

Species Reactivity:

Human

Specificity:

Detects human IL-13.

Purification Method:

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Concentration:

5mg/ml

Formulation:

Sterile, preservative-free, solution in PBS. BSA and Azide free.

Purity:

>95% by SDS-PAGE

Endotoxin:

≤ 1.0 EU/mg as determined by the LAL method

Storage:

This antibody is stable for at least 4 weeks when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at – 20°C or -80°C. Avoid repeated freeze thaw cycles.

Applications:

Functional Assays

Notes:

This biosimilar is for research use only (RUO).

Isotype Control:

Bulk Human IgG4 Isotype Control S228P (IB4)

More Information
Concentration 9.96mg/ml
Isotype Human IgG4P-Kappa
Host CHO Cells
Use Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Application Notes This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Applications Functional Assays
Storage This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Endotoxin ≤ 1.0 EU/mg as determined by the LAL method
Purity >95% by SDS-PAGE
Formulation Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purification Method This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Specificity Detects human IL-13. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Lebrikizumab.
Species Reactivity Human
Target IL-13
Shipping Conditions Blue ice
UniProt P35225
Buffer ICH3002
Sequence https://www.imgt.org/mAb-DB/
Write Your Own Review
You're reviewing:Lebrikizumab Biosimilar - Research Grade
Your Rating
Back to Top